Engineers Gate Manager LP Ascendis Pharma A/S Transaction History
Engineers Gate Manager LP
- $4.86 Billion
- Q3 2024
A detailed history of Engineers Gate Manager LP transactions in Ascendis Pharma A/S stock. As of the latest transaction made, Engineers Gate Manager LP holds 4,261 shares of ASND stock, worth $573,530. This represents 0.01% of its overall portfolio holdings.
Number of Shares
4,261
Previous 7,103
40.01%
Holding current value
$573,530
Previous $968,000
34.3%
% of portfolio
0.01%
Previous 0.02%
Shares
8 transactions
Others Institutions Holding ASND
# of Institutions
244Shares Held
58.8MCall Options Held
250KPut Options Held
377K-
Ra Capital Management, L.P. Boston, MA9.71MShares$1.31 Billion20.22% of portfolio
-
Westfield Capital Management CO LP Boston, MA5.13MShares$691 Million3.62% of portfolio
-
Avoro Capital Advisors LLC New York, NY4.99MShares$672 Million11.21% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI4.41MShares$594 Million1.03% of portfolio
-
Janus Henderson Group PLC London, X04.19MShares$564 Million0.33% of portfolio
About Ascendis Pharma A/S
- Ticker ASND
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 55,810,200
- Market Cap $7.51B
- Description
- Ascendis Pharma A/S, a biopharmaceutical company, focuses on developing therapeutics for unmet medical needs. The company offers SKYTROFA for treating patients with growth hormone deficiency (GHD). It also develops TransCon Growth Hormone (hGH) for pediatric GHD in Japan; TransCon hGH for adults with GHD; TransCon parathyroid hormone for adult h...